CINECA IRIS Institutional Research Information System

DI STEFANO, ROSARIO FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.180
AS - Asia 1.483
EU - Europa 1.425
SA - Sud America 188
AF - Africa 79
OC - Oceania 76
Totale 5.431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.060
SG - Singapore 570
IT - Italia 375
CN - Cina 311
GB - Regno Unito 185
BR - Brasile 147
VN - Vietnam 146
DE - Germania 137
IE - Irlanda 132
FI - Finlandia 97
FR - Francia 94
CA - Canada 82
AU - Australia 74
IN - India 74
SE - Svezia 72
KR - Corea 63
HK - Hong Kong 57
ES - Italia 47
JP - Giappone 43
PL - Polonia 43
NL - Olanda 39
ID - Indonesia 34
IR - Iran 33
UA - Ucraina 31
BE - Belgio 29
MX - Messico 26
TR - Turchia 26
DK - Danimarca 22
IQ - Iraq 22
BD - Bangladesh 21
PK - Pakistan 21
CH - Svizzera 18
AT - Austria 17
ZA - Sudafrica 17
AR - Argentina 12
LT - Lituania 12
PH - Filippine 12
KE - Kenya 11
CZ - Repubblica Ceca 10
MA - Marocco 10
PT - Portogallo 10
TW - Taiwan 10
CO - Colombia 9
GH - Ghana 9
GR - Grecia 9
NG - Nigeria 9
IL - Israele 8
RS - Serbia 8
CL - Cile 7
HR - Croazia 7
EC - Ecuador 6
EG - Egitto 6
MY - Malesia 6
TN - Tunisia 6
NO - Norvegia 5
SA - Arabia Saudita 5
HU - Ungheria 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
JO - Giordania 3
KZ - Kazakistan 3
LY - Libia 3
RU - Federazione Russa 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BJ - Benin 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
MT - Malta 2
NE - Niger 2
NI - Nicaragua 2
PR - Porto Rico 2
UZ - Uzbekistan 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
FJ - Figi 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
Totale 5.428
Salva come PNG Salva come JPEG
Città #
Singapore 338
Ashburn 256
Chandler 193
Santa Clara 186
San Jose 177
Dublin 127
Beijing 104
Helsinki 60
Turin 58
Fairfield 54
Nyköping 53
Los Angeles 49
New York 48
Munich 47
Ho Chi Minh City 45
Dallas 44
Seoul 39
Lauterbourg 37
Torino 36
Hong Kong 33
Redwood City 32
Columbus 31
Hanoi 31
London 31
The Dalles 31
Hefei 30
Tokyo 30
Wilmington 27
Woodbridge 25
Seattle 24
Houston 23
Milan 23
Turku 22
Medford 21
Montreal 21
Pisa 21
São Paulo 21
Binbrook 20
Chennai 20
Jakarta 20
Princeton 20
Rome 20
Düsseldorf 19
Kalundborg 18
Cambridge 17
Dong Ket 16
Frankfurt am Main 16
Peoria 16
Warsaw 16
Buffalo 15
Nuremberg 15
Fremont 14
Guangzhou 14
Hangzhou 14
Lappeenranta 14
Chicago 13
Madrid 13
Vienna 13
Brisbane 12
Manchester 12
Redondo Beach 12
Schiffdorf 12
Boston 11
Shanghai 11
Toronto 11
Boardman 10
Dearborn 10
Johannesburg 10
Orem 10
Sydney 10
Bengaluru 9
Genoa 9
Istanbul 9
Philadelphia 9
Silver Spring 9
Valencia 9
Adelaide 8
Brooklyn 8
Council Bluffs 8
Nairobi 8
Paris 8
San Diego 8
Atlanta 7
Brussels 7
Camden 7
Central 7
Chengdu 7
Da Nang 7
Gangdong-gu 7
Isfahan 7
Jacksonville 7
Liverpool 7
Melbourne 7
Taipei 7
Amsterdam 6
Ankara 6
Ann Arbor 6
Belgrade 6
Croydon 6
Derby 6
Totale 3.124
Salva come PNG Salva come JPEG
Nome #
Hormonal treatment and quality of life of prostate cancer patients: new evidences 914
Renal cell carcinoma (RCC): Fatter is better? A review on the role of obesity in RCC 346
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 309
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 272
Fatigue in lung cancer patients: symptom burden and management of challenges. 209
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 205
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate 182
Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data 180
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit 164
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave 147
LATITUDE and other coordinates in quality of life of prostate cancer patients 142
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond 128
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis 126
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications 126
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 124
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer 123
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 121
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma 117
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel 117
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 116
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? 115
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis 115
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 112
Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report 112
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 110
Prognostic factors in metastatic castration resistant prostate cancer patients treated with Radium-223: a retrospective study 107
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy 102
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 101
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide 98
Therapeutic sequencing in advanced renal cell carcinoma: how to choose considering clinical and biological factors 97
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 80
A new era for radium-223? Optimizing treatment by balancing efficacy and toxicity through combination therapies 71
Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology 69
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives 65
Totale 5.522
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 0 17 43
2021/2022411 40 18 20 9 15 6 22 25 19 57 128 52
2022/2023852 52 90 33 59 84 152 57 63 99 51 65 47
2023/2024580 52 71 41 58 32 83 62 40 9 42 35 55
2024/20251.110 47 84 62 87 221 89 36 64 112 66 89 153
2025/20261.937 290 101 137 244 231 89 371 84 194 135 61 0
Totale 5.522